260 related articles for article (PubMed ID: 27804122)
1. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus.
Chakkera HA; Kudva Y; Kaplan B
Clin Pharmacol Ther; 2017 Jan; 101(1):114-120. PubMed ID: 27804122
[TBL] [Abstract][Full Text] [Related]
2. [Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus].
Ippoliti GB; Viganò M
G Ital Nefrol; 2003; 20 Suppl 25():S11-4. PubMed ID: 14523907
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers.
Øzbay LA; Møller N; Juhl C; Bjerre M; Carstens J; Rungby J; Jørgensen KA
Br J Clin Pharmacol; 2012 Apr; 73(4):536-45. PubMed ID: 21988494
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells.
Øzbay LA; Smidt K; Mortensen DM; Carstens J; Jørgensen KA; Rungby J
Br J Pharmacol; 2011 Jan; 162(1):136-46. PubMed ID: 20825407
[TBL] [Abstract][Full Text] [Related]
5. The safety of calcineurin inhibitors for kidney-transplant patients.
Malvezzi P; Rostaing L
Expert Opin Drug Saf; 2015 Oct; 14(10):1531-46. PubMed ID: 26329325
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.
Triñanes J; Rodriguez-Rodriguez AE; Brito-Casillas Y; Wagner A; De Vries APJ; Cuesto G; Acebes A; Salido E; Torres A; Porrini E
Am J Transplant; 2017 Nov; 17(11):2829-2840. PubMed ID: 28432716
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibition and new-onset diabetes mellitus after transplantation.
Chakkera HA; Mandarino LJ
Transplantation; 2013 Mar; 95(5):647-52. PubMed ID: 23076551
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin is an important factor involved in glucose uptake in human adipocytes.
Fonseca ACRG; Carvalho E; Eriksson JW; Pereira MJ
Mol Cell Biochem; 2018 Aug; 445(1-2):157-168. PubMed ID: 29380240
[TBL] [Abstract][Full Text] [Related]
9. Optimization of the use of Calcineurin inhibitors in liver transplantation.
de Mare-Bredemeijer EL; Metselaar HJ
Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
[TBL] [Abstract][Full Text] [Related]
10. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
[TBL] [Abstract][Full Text] [Related]
11. A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion.
Kim I; Kang ES; Yim YS; Ko SJ; Jeong SH; Rim JH; Kim YS; Ahn CW; Cha BS; Lee HC; Kim CH
Pharmacogenomics J; 2011 Jun; 11(3):191-8. PubMed ID: 20351753
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors: 40 years later, can't live without ..
Azzi JR; Sayegh MH; Mallat SG
J Immunol; 2013 Dec; 191(12):5785-91. PubMed ID: 24319282
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions.
Rangel EB
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1585-605. PubMed ID: 25255841
[TBL] [Abstract][Full Text] [Related]
14. The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients.
Ozbay LA; Møller N; Juhl C; Bjerre M; Carstens J; Rungby J; Jørgensen KA
Diabet Med; 2012 Dec; 29(12):e440-4. PubMed ID: 23003106
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor (CNI)-associated skin cancers: New insights on exploring mechanisms by which CNIs downregulate DNA repair machinery.
Ume AC; Pugh JM; Kemp MG; Williams CR
Photodermatol Photoimmunol Photomed; 2020 Nov; 36(6):433-440. PubMed ID: 32786098
[TBL] [Abstract][Full Text] [Related]
16. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
Tamura K
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
[No Abstract] [Full Text] [Related]
17. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors.
van den Hoogen MW; van der Hoeven AM; Hilbrands LB
Exp Clin Transplant; 2013 Jun; 11(3):234-8. PubMed ID: 23432070
[TBL] [Abstract][Full Text] [Related]
18. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients.
David-Neto E; Lemos FC; Fadel LM; Agena F; Sato MY; Coccuza C; Pereira LM; de Castro MC; Lando VS; Nahas WC; Ianhez LE
Transplantation; 2007 Jul; 84(1):50-5. PubMed ID: 17627237
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitors and male fertility after renal transplantation - a review.
Georgiou GK; Dounousi E; Harissis HV
Andrologia; 2016 Jun; 48(5):483-90. PubMed ID: 26341518
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
